Off The Slow Track? Plan B Resubmission Expected Within Two Weeks, Barr Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The latest version of Barr's application will likely seek dual Rx/OTC status, with 18 as the age break for OTC sale.